Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Curious to know what apps are available to you to help you manage a variety of health conditions? At the ADCES 2021 conference, experts discussed the best options out...
Navigating health insurance can be tricky. We’ve compiled a list of the most common terms you might come across to minimize any confusion in the terminology.
Julie Heverly describes one harrowing day when her glucose levels teetered between way too high and way too low and how she navigated this challenge.
diaTribe’s Community Manager Cherise Shockley led an online discussion about Time in Range with Shay Webb, a diabetes advocate, and Julia Blanchette, a diabetes care and...
The AP Workshop – A Meeting of the Great Minds Working to Close the Loop
Dr. Judith Fradkin, Director of the Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK
The Association of Diabetes Care and Education Specialists 2021 conference covered the impacts of diabetes stigma, smart MDI therapies, insulin delivery by means other...
Social determinants of health describe the interaction between social, economic, and environmental factors and how they can influence a person’s health. Read below for...
Noted cardiologist, Dr. Nissen on Avandia.
Symlin Makes You Smile - 9 hours, 9 months and the "Post-Sex Buzz."
Drug and device companies are increasingly using “direct-to-consumer” marketing to diabetic patients as well as to doctors and educators. As we’ve written, this can be a...
Caps off to this intensive manager, Phil Southerland.
Live from DT, EASD, AADE and TCOYD.
Jenna Scarsi, a diabetes educator from the Chicago area with type 1 diabetes, recently won the Bayer Dream Fund, an annual $100,000 fellowship to help people accomplish...
Symlin: A Sleeper Drug Slowly Rises
(S)he said what?!?
In previous issues, we’ve documented the arduous journey of Orexigen’s anti-obesity drug Contrave through the regulatory process. In December, an FDA Advisory Committee...
New from J&J’s Animas/OneTouch is the OneTouch Ping Glucose Management System. This represents a positive step in pump convenience and (dare we say) “cool” factor...
Kerri downloads from day 1.
Have you been tested for Chronic Kidney Disease?

Pages